| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer
|
Büntzel, Jens
|
|
2002
|
|
1S1 |
p. 4-13
10 p.
|
artikel
|
| 2 |
A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer
|
Rani Anné, Pramila
|
|
2002
|
|
1S1 |
p. 18-19
2 p.
|
artikel
|
| 3 |
A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers
|
Zoberi, Imran
|
|
2002
|
|
1S1 |
p. 14-17
4 p.
|
artikel
|
| 4 |
Differential activation of nuclear transcription factor κB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells
|
Grdina, David J.
|
|
2002
|
|
1S1 |
p. 103-111
9 p.
|
artikel
|
| 5 |
Esophageal cancer and the esophagus: Challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment
|
Jatoi, Aminah
|
|
2002
|
|
1S1 |
p. 62-67
6 p.
|
artikel
|
| 6 |
Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation therapy oncology group trial 98-01
|
Movsas, Benjamin
|
|
2002
|
|
1S1 |
p. 40-45
6 p.
|
artikel
|
| 7 |
Intrarectal application of amifostine for the prevention of radiation-induced rectal injury
|
Ben-Josef, Edgar
|
|
2002
|
|
1S1 |
p. 81-85
5 p.
|
artikel
|
| 8 |
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation
|
Arquette, Matthew
|
|
2002
|
|
1S1 |
p. 59-61
3 p.
|
artikel
|
| 9 |
Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy
|
Werner-Wasik, Maria
|
|
2002
|
|
1S1 |
p. 34-39
6 p.
|
artikel
|
| 10 |
Preclinical modeling of improved amifostine (ethyol) use in radiation therapy
|
Cassatt, David R.
|
|
2002
|
|
1S1 |
p. 97-102
6 p.
|
artikel
|
| 11 |
Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer
|
Clifford Chao, K.S.
|
|
2002
|
|
1S1 |
p. 20-25
6 p.
|
artikel
|
| 12 |
Radiation pneumonitis and early circulatory cytokine markers
|
Chen, Yuhchyau
|
|
2002
|
|
1S1 |
p. 26-33
8 p.
|
artikel
|
| 13 |
Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer
|
Anlonadou, Dosia
|
|
2002
|
|
1S1 |
p. 50-58
9 p.
|
artikel
|
| 14 |
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results
|
R., Komaki
|
|
2002
|
|
1S1 |
p. 46-49
4 p.
|
artikel
|
| 15 |
Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma
|
Myerson, Robert
|
|
2002
|
|
1S1 |
p. 86-90
5 p.
|
artikel
|
| 16 |
Statistical issues in studies of toxicity modifiers
|
Scott, Charles
|
|
2002
|
|
1S1 |
p. 91-96
6 p.
|
artikel
|
| 17 |
The evolution and application of toxicity criteria
|
Trotti, Andy
|
|
2002
|
|
1S1 |
p. 1-3
3 p.
|
artikel
|
| 18 |
The potential role of amifostine in the treatment of carcinoma of the uterine cervix: A review
|
Small Jr, William
|
|
2002
|
|
1S1 |
p. 68-74
7 p.
|
artikel
|
| 19 |
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on radiation therapy oncology group 9406
|
Michalski, Jeff M.
|
|
2002
|
|
1S1 |
p. 75-80
6 p.
|
artikel
|
Tijdschrift beschrijving